Related Experiment Video

Updated: May 21, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Carbohydrate-based cancer vaccines: target cancer with sugar bullets

Chang-Cheng Liu1, Xin-Shan Ye

  • 1State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.

Glycoconjugate Journal
|June 7, 2012
PubMed

Insights

Scientists are developing new strategies to improve cancer vaccines targeting tumor-associated carbohydrate antigens (TACAs). These approaches aim to overcome the weak immune response often seen with TACAs, enhancing their potential for cancer immunotherapy.

Area of Science:

  • Glycobiology and Glycochemistry
  • Cancer Immunotherapy

Background:

  • Tumor-associated carbohydrate antigens (TACAs) are increasingly identified as specific targets for cancer vaccines and immunotherapies.
  • Most TACAs function as T cell-independent antigens, eliciting insufficient immune responses for effective cancer treatment.
  • Endogenous properties and patient immune status contribute to immunotolerance and immunosuppression against TACAs.

Purpose of the Study:

  • To review recent advancements in overcoming immunotolerance and immunosuppression associated with TACAs.
  • To explore strategies for enhancing the immunogenicity of TACAs for improved cancer immunotherapy.

Main Methods:

  • Coupling carbohydrate antigens to suitable carriers, such as proteins or small molecules.
  • Chemical modification of TACA structures to boost immunogenicity.
  • Review of literature on strategies to break TACA-induced immunotolerance.

Main Results:

  • Development of methods to enhance TACA immunogenicity.
  • Strategies identified to overcome T cell-independent antigen limitations.
  • Approaches to break immunotolerance and immunosuppression in cancer patients.

Conclusions:

  • Coupling TACAs to carriers and chemical modifications are promising strategies.
  • These methods can enhance TACA immunogenicity and overcome immune tolerance.
  • Advancements offer new avenues for developing effective cancer vaccines and immunotherapies.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.